Skip to main content

LETTER TO THE EDITOR

Int J Public Health, 31 August 2022

Periodontitis as a Risk of Hospitalization and Death by SARS-CoV-2

Shipra GuptaShipra Gupta1Ismo T. RisnenIsmo T. Räisänen2Timo Sorsa
Timo Sorsa2*
  • 1Oral Health Sciences Centre, Post Graduate Institute of Medical Education & Research, Chandigarh, India
  • 2University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Dear Editors,

We concur with the observations of Mauer et al. [1] addressing the comparative analysis of risks of hospitalization, clinical outcomes and death due to SARS-CoV-2 in patients hospitalized in Lombardy. Affordable precision/personalized medicine which combines the patients clinical data with lab-on-a-chip biomarkers, imaging and point-of-care diagnostics is the way forward if we want to dispense quality care to patients. Among real time monitoring of COVID-19 related risk diseases, it is pertinent to monitor oral and periodontal health, when we take into perspective the probability of poor gum health contributing to the COVID-19 related hospitalization and other adverse outcomes [24].

Sufficient evidence in literature underscores the importance of oral health, with emphasis on the prevention and treatment of periodontitis, linking it with many systemic diseases, and now with COVID-19 [35]. The same is suggested by the sample of 78 COVID-19 positive (delta variant) patients from India among whom patients with periodontitis were significantly more likely to need hospital admission, assisted ventilation or have COVID-19 related pneumonia than the periodontally healthy patients (p < 0.05; Table 1) [3]. Further studies are warranted to address the effect of oral and periodontal health on hospitalization and death due to other COVID-19 variants.

TABLE 1
www.frontiersin.org

TABLE 1. Association between Periodontal disease status (Healthy, Gingivitis, Periodontitis) and Hospital admission, COVID-19 related pneumonia and assisted ventilation among 78 Indian COVID-19 positive patients (India, 2021).

Ethics Statement

The studies involving human participants were reviewed and approved by the Postgraduate Institute of Medical Education and Research, Chandigarh, India Institutional Ethics Committee (INT/IEC/2021/SPL-636). The patients/participants provided their written informed consent to participate in this study.

Author Contributions

SG contributed to conceptualization, data curation, analysis and writing-original draft. Analysis and writing-review and editing was done by IR and TS. SG has directly accessed and verified the data reported in the manuscript.

Funding

This work was carried out as a part of routine COVID-19 diagnostic activity of the Regional Virus Diagnostic Laboratory under ICMR New Delhi, by the Department of Virology, PGIMER, Chandigarh.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1. Mauer, N, Chiecca, G, Carioli, G, Gianfredi, V, Iacoviello, L, Bertagnolio, S, et al. The First 110, 593 COVID-19 Patients Hospitalised in Lombardy: A Regionwide Analysis of Case Characteristics, Risk Factors and Clinical Outcomes. Int J Public Health (2022) 67:1604427. doi:10.3389/ijph.2022.1604427

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Sorsa, T, Sahni, V, Buduneli, N, Gupta, S, Räisänen, IT, Golub, LM, et al. Active Matrix Metalloproteinase-8 (aMMP-8) point-of-care Test (POCT) in the COVID-19 Pandemic. Expert Rev Proteomics (2021) 18(8):707–17. Epub 2021 Sep 11. PMID: 34468272; PMCID: PMC8442753. doi:10.1080/14789450.2021.1976151

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Gupta, S, Mohindra, R, Singla, M, Khera, S, Sahni, V, Kanta, P, et al. The Clinical Association between Periodontitis and COVID-19. Clin Oral Investig (2022) 26(2):1361–74. doi:10.1007/s00784-021-04111-3

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Gupta, S, Saarikko, M, Pfützner, A, Räisänen, IT, and Sorsa, T. Compromised Periodontal Status Could Increase Mortality for Patients with COVID-19. Lancet Infect Dis (2022) 22(3):314. doi:10.1016/S1473-3099(22)00065-2

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Genco, RJ, and Sanz, M. Clinical and Public Health Implications of Periodontal and Systemic Diseases: An Overview. Periodontol 2000 (2020) 83(1):7–13. doi:10.1111/prd.12344

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: COVID-19, oral health, death, prevention, ventilation

Citation: Gupta S, Räisänen IT and Sorsa T (2022) Periodontitis as a Risk of Hospitalization and Death by SARS-CoV-2. Int J Public Health 67:1605156. doi: 10.3389/ijph.2022.1605156

Received: 22 June 2022; Accepted: 22 July 2022;
Published: 31 August 2022.

Edited by:

Olaf Von Dem Knesebeck, University Medical Center Hamburg-Eppendorf, Germany

Copyright © 2022 Gupta, Räisänen and Sorsa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Timo Sorsa, timo.sorsa@helsinki.fi

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.